Healthcare provider profile · identity verified

Jonathan Nicholas Byrd, MD

Internal Medicine · SAINT LOUIS, MO · NPI 1063707966

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	709	189
Amlodipine Besylate	Amlodipine Besylate	671	178
Levothyroxine Sodium	Levothyroxine Sodium	401	102
Losartan Potassium	Losartan Potassium	391	97
Pravastatin Sodium	Pravastatin Sodium	366	99
Omeprazole	Omeprazole	320	83
Lisinopril	Lisinopril	312	91
Hydrochlorothiazide	Hydrochlorothiazide	275	79
Gabapentin	Gabapentin	239	55
Metoprolol Succinate	Metoprolol Succinate	225	55
Olmesartan Medoxomil	Olmesartan Medoxomil	217	55
Eliquis	Apixaban	211	40
Rosuvastatin Calcium	Rosuvastatin Calcium	186	53
Tamsulosin Hcl	Tamsulosin Hcl	178	48
Metformin Hcl	Metformin Hcl	166	49
Escitalopram Oxalate	Escitalopram Oxalate	162	41
Meloxicam	Meloxicam	157	32
Atenolol	Atenolol	151	39
Ozempic	Semaglutide	150	21
Albuterol Sulfate Hfa	Albuterol Sulfate	139	42
Furosemide	Furosemide	138	39
Trazodone Hcl	Trazodone Hcl	135	40
Bupropion Xl	Bupropion Hcl	133	35
Famotidine	Famotidine	133	34
Pantoprazole Sodium	Pantoprazole Sodium	125	38
Simvastatin	Simvastatin	120	34
Sertraline Hcl	Sertraline Hcl	117	29
Arexvy	Rsvpref3 Antigen/As01e/Pf	111	110
Metformin Hcl Er	Metformin Hcl	111	32
Tramadol Hcl	Tramadol Hcl	110	27
Carvedilol	Carvedilol	106	32
Alendronate Sodium	Alendronate Sodium	103	28
Montelukast Sodium	Montelukast Sodium	103	30
Duloxetine Hcl	Duloxetine Hcl	96	19
Potassium Chloride	Potassium Chloride	94	23
Fluticasone Propionate	Fluticasone Propionate	89	32
Trulicity	Dulaglutide	88	11
Mounjaro	Tirzepatide	86	16
Lorazepam	Lorazepam	85	24
Allopurinol	Allopurinol	72	20
Valsartan	Valsartan	71	19
Triamcinolone Acetonide	Triamcinolone Acetonide	69	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	20
Synthroid	Levothyroxine Sodium	68	13
Zolpidem Tartrate	Zolpidem Tartrate	68	18
Finasteride	Finasteride	66	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	17
Celecoxib	Celecoxib	58	18
Ezetimibe	Ezetimibe	57	16
Jardiance	Empagliflozin	54	16
Spironolactone	Spironolactone	54	18
Nebivolol Hcl	Nebivolol Hcl	52	14
Citalopram Hbr	Citalopram Hydrobromide	50	12
Doxazosin Mesylate	Doxazosin Mesylate	50	14
Paroxetine Hcl	Paroxetine Hcl	50	suppressed
Belsomra	Suvorexant	49	suppressed
Tizanidine Hcl	Tizanidine Hcl	49	13
Eszopiclone	Eszopiclone	48	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	suppressed
Clopidogrel	Clopidogrel Bisulfate	47	15
Xarelto	Rivaroxaban	47	suppressed
Clonazepam	Clonazepam	45	suppressed
Lovastatin	Lovastatin	45	12
Pregabalin	Pregabalin	45	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	12
Mirtazapine	Mirtazapine	42	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	41	suppressed
Temazepam	Temazepam	40	suppressed
Ipratropium Bromide	Ipratropium Bromide	37	17
Prednisone	Prednisone	37	22
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	37	suppressed
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	11
Fenofibrate	Fenofibrate	34	suppressed
Myrbetriq	Mirabegron	33	suppressed
Irbesartan	Irbesartan	32	suppressed
Valacyclovir	Valacyclovir Hcl	32	17
Doxepin Hcl	Doxepin Hcl	30	suppressed
Rybelsus	Semaglutide	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Azelastine Hcl	Azelastine Hcl	28	16
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	27	suppressed
Telmisartan	Telmisartan	27	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Dilt-Xr	Diltiazem Hcl	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Estradiol	Estradiol	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Diazepam	Diazepam	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	11
Propranolol Hcl	Propranolol Hcl	22	suppressed
Mupirocin	Mupirocin	21	14
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Wegovy	Semaglutide	18	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	17	suppressed
Ramipril	Ramipril	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Repatha Sureclick	Evolocumab	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Febuxostat	Febuxostat	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Minoxidil	Minoxidil	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Trulance	Plecanatide	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Techlite Pen Needle	Pen Needle, Diabetic	12	suppressed
Unifine Pentips Plus	Pen Needle, Diabetic	12	suppressed
Baclofen	Baclofen	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	11	suppressed
Crestor	Rosuvastatin Calcium	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error